Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings (ORGO) Financial Statements


Organogenesis Holdings Financial Overview

Organogenesis Holdings's market cap is currently ―. The company's EPS TTM is $0.043; its P/E ratio is 57.49; Organogenesis Holdings is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 99.65M$ 108.53M$ 117.32M$ 107.64M$ 114.52M
Gross Profit$ 71.88M$ 82.74M$ 117.32M$ 81.03M$ 87.41M
EBIT$ -1.29M$ 8.08M$ 9.77M$ -3.98M$ 7.72M
EBITDA$ 11.00M-$ 15.18M$ 1.89M$ 12.28M
Net Income Common Stockholders$ -569.00K$ 3.17M$ 5.32M$ -2.97M$ 6.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 103.84M$ 98.23M$ 89.51M$ 89.42M$ 103.29M
Total Assets$ 460.02M$ 462.65M$ 450.31M$ 446.11M$ 449.36M
Total Debt$ 98.98M$ 122.81M$ 122.67M$ 122.35M$ 123.79M
Net Debt$ -4.86M$ 24.59M$ 33.16M$ 32.94M$ 20.50M
Total Liabilities$ 181.36M$ 185.78M$ 179.03M$ 182.41M$ 183.69M
Stockholders Equity$ 278.66M$ 276.87M$ 271.28M$ 263.70M$ 265.67M
Cash Flow-
Free Cash Flow$ 7.29M-$ 1.15M$ -12.64M$ -2.86M
Operating Cash Flow$ 10.61M$ 16.73M$ 8.65M$ -5.08M$ 7.80M
Investing Cash Flow$ -3.32M$ -5.98M$ -7.50M$ -7.56M$ -10.66M
Financing Cash Flow$ -1.78M$ -1.44M$ -1.05M$ -1.24M$ -1.88M
Currency in USD

Organogenesis Holdings Earnings and Revenue History

Organogenesis Holdings Debt to Assets

Organogenesis Holdings Cash Flow

Organogenesis Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis